Drug price controls may shorten lives: report
CHICAGO (Reuters) - Imposing European-style price controls on prescription drugs in the United States would result in modest cost savings that would be more than offset by shortened life spans as the pace of drug innovation slows, U.S. researchers said on Tuesday.<div class="feedflare">
<img src="http://feedproxy.google.com/~f/reuters/healthNews?d=41" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=3xZmILLr) <img src="http://feedproxy.google.com/~f/reuters/healthNews?i=K5RuMoc2" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=K5RuMoc2) <img src="http://feedproxy.google.com/~f/reuters/healthNews?i=PR64BW8y" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=PR64BW8y)
</div><img src="http://feedproxy.google.com/~r/reuters/healthNews/~4/iqwhGJnqigY" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/healthNews/~3/iqwhGJnqigY/idUSTRE4BF0WX20081216